Accueil>>Signaling Pathways>> PROTAC>>FKBP12 PROTAC dTAG-7

FKBP12 PROTAC dTAG-7 (Synonyms: dTAG-7)

Catalog No.GC39289

FKBP12 PROTAC dTAG-7 (dTAG-7) est un dégradeur hétérobifonctionnel. FKBP12 PROTAC dTAG-7 (dTAG-7) est un dégradeur de FKBP12F36V avec expression de FKBP12F36V dans le cadre avec une protéine d'intérêt. FKBP12 PROTAC dTAG-7 (dTAG-7) est également un dégradeur sélectif du co-activateur transcriptionnel du bromodomaine BET BRD4 en reliant les bromodomaines BET À une ligase d'ubiquitine E3 CRBN.

Products are for research use only. Not for human use. We do not sell to patients.

FKBP12 PROTAC dTAG-7 Chemical Structure

Cas No.: 2064175-32-0

Taille Prix Stock Qté
50mg Please Inquire Please Inquire
5mg
405,00 $US
En stock
10mg
720,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

FKBP12 PROTAC dTAG-7 (dTAG-7) is a heterobifunctional degrader. FKBP12 PROTAC dTAG-7 (dTAG-7) is a degrader of FKBP12F36V with expression of FKBP12F36V in-frame with a protein of interest. FKBP12 PROTAC dTAG-7 (dTAG-7) also is a selective degrader of BET bromodomain transcriptional co-activator BRD4 by bridging BET bromodomains to an E3 ubiquitin ligase CRBN[1].

[1]. Nabet B, et al. The dTAG system for immediate and target-specific protein degradation. Nat Chem Biol. 2018 May;14(5):431-441.

Avis

Review for FKBP12 PROTAC dTAG-7

Average Rating: 5 ★★★★★ (Based on Reviews and 17 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for FKBP12 PROTAC dTAG-7

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.